These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24040196)

  • 1. Mitochondrial haplotypes associated with biomarkers for Alzheimer's disease.
    Ridge PG; Koop A; Maxwell TJ; Bailey MH; Swerdlow RH; Kauwe JS; Honea RA;
    PLoS One; 2013; 8(9):e74158. PubMed ID: 24040196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic study of multimodal imaging Alzheimer's disease progression score implicates novel loci.
    Scelsi MA; Khan RR; Lorenzi M; Christopher L; Greicius MD; Schott JM; Ourselin S; Altmann A
    Brain; 2018 Jul; 141(7):2167-2180. PubMed ID: 29860282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonlinear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's disease.
    Popescu SG; Whittington A; Gunn RN; Matthews PM; Glocker B; Sharp DJ; Cole JH;
    Hum Brain Mapp; 2020 Oct; 41(15):4406-4418. PubMed ID: 32643852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
    Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L;
    Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
    Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
    Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
    Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
    Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs.
    Pereira JB; Cavallin L; Spulber G; Aguilar C; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Aarsland D; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2014 Mar; 275(3):317-30. PubMed ID: 24118559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of EPHA1 genetic variation on cerebrospinal fluid and neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
    Wang HF; Tan L; Hao XK; Jiang T; Tan MS; Liu Y; Zhang DQ; Yu JT;
    J Alzheimers Dis; 2015; 44(1):115-23. PubMed ID: 25182741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.
    Altomare D; Ferrari C; Caroli A; Galluzzi S; Prestia A; van der Flier WM; Ossenkoppele R; Van Berckel B; Barkhof F; Teunissen CE; Wall A; Carter SF; Schöll M; Choo ILH; Grimmer T; Redolfi A; Nordberg A; Scheltens P; Drzezga A; Frisoni GB;
    J Neurol; 2019 Oct; 266(10):2535-2545. PubMed ID: 31267207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
    Sintini I; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Martin PR; Jones DT; Boeve BF; Knopman DS; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Brain; 2020 Jul; 143(7):2281-2294. PubMed ID: 32572464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How early can we predict Alzheimer's disease using computational anatomy?
    Adaszewski S; Dukart J; Kherif F; Frackowiak R; Draganski B;
    Neurobiol Aging; 2013 Dec; 34(12):2815-26. PubMed ID: 23890839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment.
    Wang WY; Liu Y; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT;
    Mol Neurobiol; 2017 Mar; 54(2):1111-1118. PubMed ID: 26803496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.
    Schuff N; Woerner N; Boreta L; Kornfield T; Shaw LM; Trojanowski JQ; Thompson PM; Jack CR; Weiner MW;
    Brain; 2009 Apr; 132(Pt 4):1067-77. PubMed ID: 19251758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial genomic analysis of late onset Alzheimer's disease reveals protective haplogroups H6A1A/H6A1B: the Cache County Study on Memory in Aging.
    Ridge PG; Maxwell TJ; Corcoran CD; Norton MC; Tschanz JT; O'Brien E; Kerber RA; Cawthon RM; Munger RG; Kauwe JS
    PLoS One; 2012; 7(9):e45134. PubMed ID: 23028804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
    J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
    Madusanka N; Choi HK; So JH; Choi BK; Park HG
    Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.